The sympathetic nervous system in heart failure

Area of Science:

• Cardiology
• Neuroscience
• Physiology

Background:

• Clinical heart failure (CHF) is associated with increased sympathetic nervous system (SNS) activity.
• This heightened SNS activity contributes to elevated vascular tone, impairing left ventricular systolic function.
• Patients exhibit both increased resting SNS activity and a blunted response to physiological stressors.

Purpose of the Study:

• To investigate the role and implications of sympathetic nervous system (SNS) activation in clinical heart failure (CHF).
• To determine if SNS abnormalities in CHF are functional and potentially reversible.
• To explore the relationship between SNS activation and mortality in CHF patients.

Main Methods:

• The study likely involved observational analysis of SNS activity in CHF patients.
• Assessment of SNS response to physiological stressors such as orthostasis and exercise.
• Comparison of SNS activity before and after heart transplantation.

Main Results:

• Elevated resting sympathetic nervous system (SNS) activity was confirmed in clinical heart failure (CHF) patients.
• A diminished SNS response to physiological stress was observed.
• Heart transplantation normalized both resting SNS activity and reflex responsiveness, indicating a functional basis.
• The degree of SNS activation correlated directly with mortality in CHF.

Conclusions:

• Sympathetic nervous system (SNS) hyperactivity is a key feature of clinical heart failure (CHF), impacting cardiac performance and prognosis.
• These SNS abnormalities are functional and can be reversed, notably through heart transplantation.
• Heightened SNS activity serves as a significant risk factor or marker for mortality in CHF, suggesting therapeutic potential for SNS inhibition.